Europe Pharmaceutical Plastic Packaging Market Size (2024 - 2029)

Europe Pharmaceutical Plastic Packaging Market Analysis

The Europe Pharmaceutical Plastic Packaging Market size is estimated at USD 13.69 billion in 2024, and is expected to reach USD 17.61 billion by 2029, growing at a CAGR of 5.17% during the forecast period (2024-2029).

Advantages associated with plastic packaging materials and products, such as their lightweight, low cost, flexibility, mechanical strength, and stability, make them suitable for use in the European pharmaceutical packaging market.

• The growing adoption of blister packs in pharmaceutical packaging, which provides convenient methods to store and transport solid medicinal products, such as tablets and capsules, is fueling the demand for plastic packaging.
• Due to the low fragile nature and light weight of plastic bottles, European pharmaceutical companies increasingly prefer plastic bottles for cough syrups and other liquid drug packaging for better profit margins, supporting the growth of plastic packaging in the studied market.
• Rigid plastic bottles and vials offer better barrier properties, protecting medication from moisture and contamination. They are lightweight, easy to handle, and come in various sizes, supporting the growth adoption of plastic packaging in the pharmaceutical industry. Flexible plastic pouches and blister packs are convenient for unit-does dispensing and on-the-go medication use.
• The development of better and advanced healthcare infrastructure in Europe is driving the pharmaceutical plastic packaging market, considering logistical aspects like cold chain requirements for vaccines since advanced healthcare facilities usually have robust cold chain infrastructure for storing and transporting temperature-sensitive medications like vaccines.
• The Red Sea crisis emerged from the Israel and Hamas conflict. It generated missile attacks against merchant and naval vessels in the Red Sea, which disrupted the supply chain route of resins and plastic raw materials to Europe from Middle Eastern countries, raising the price of raw materials in the ecosystem thereby hindering the market’s growth.
• In April 2024, Flexible Packaging Europe, the industry association for all types of flexible packaging manufacturers, reported that supply chain disruptions due to the shipping disruptions in the Red Sea had a significant impact on supply chains, leading to increased prices of European flexible packaging materials, including plastic packaging material, in the first quarter of 2024. This negatively impacted the growth of the European market.

Europe Pharmaceutical Plastic Packaging Industry Segmentation

The market is defined by the revenues accrued from the sales of different pharmaceutical plastic packaging products offered by various vendors operating in the European region. The market scope considers the revenue generated from multiple plastic raw material-based products used for pharmaceutical packaging in different European countries.

The European pharmaceutical plastic packaging market is segmented by raw material (polypropylene (PP), polyethylene terephthalate (PET), low density polyethylene (LDPE), high density polyethylene (HDPE), and other types of materials), by product type (solid containers, dropper bottles, nasal spray bottles, liquid bottles, oral care, pouches, vials and ampoules, cartridges, syringes, caps and closures, and other product types), and by country (United Kingdom, Germany, France, Spain, Italy, and Rest of Europe). The report offers the market size in value terms in USD for all the abovementioned segments.